These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 21136060

  • 1. Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin.
    Holweger K, Lipp HP, Beijnen JH, Bokemeyer C, Hartmann JT.
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):693-701. PubMed ID: 21136060
    [Abstract] [Full Text] [Related]

  • 2. Novel algorithm for more accurate calculation of renal function in adults with cancer.
    Holweger K, Lipp HP, Dietz K, Hartmann JT, Bokemeyer C.
    Ann Pharmacother; 2008 Dec; 42(12):1749-57. PubMed ID: 19033483
    [Abstract] [Full Text] [Related]

  • 3. Flat dosing of carboplatin is justified in adult patients with normal renal function.
    Ekhart C, de Jonge ME, Huitema AD, Schellens JH, Rodenhuis S, Beijnen JH.
    Clin Cancer Res; 2006 Nov 01; 12(21):6502-8. PubMed ID: 17085665
    [Abstract] [Full Text] [Related]

  • 4. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
    Nagao S, Fujiwara K, Imafuku N, Kagawa R, Kozuka Y, Oda T, Maehata K, Ishikawa H, Koike H, Aotani E, Kohno I.
    Gynecol Oncol; 2005 Nov 01; 99(2):327-33. PubMed ID: 16005943
    [Abstract] [Full Text] [Related]

  • 5. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
    Okamoto H, Nagatomo A, Kunitoh H, Kunikane H, Watanabe K.
    Cancer Chemother Pharmacol; 1998 Nov 01; 42(4):307-12. PubMed ID: 9744776
    [Abstract] [Full Text] [Related]

  • 6. Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?
    Ekhart C, Rodenhuis S, Schellens JH, Beijnen JH, Huitema AD.
    Cancer Chemother Pharmacol; 2009 Jun 01; 64(1):115-22. PubMed ID: 18989671
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.
    de Lemos ML, Hsieh T, Hamata L, Levin A, Swenerton K, Djurdjev O, Vu T, Hu F, Conklin J, Malfair Taylor SC.
    Gynecol Oncol; 2006 Dec 01; 103(3):1063-9. PubMed ID: 16875719
    [Abstract] [Full Text] [Related]

  • 9. Prospective evaluation of carboplatin AUC dosing in patients with a BMI>or=27 or cachexia.
    Herrington JD, Tran HT, Riggs MW.
    Cancer Chemother Pharmacol; 2006 Jan 01; 57(2):241-7. PubMed ID: 16133538
    [Abstract] [Full Text] [Related]

  • 10. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
    Donahue A, McCune JS, Faucette S, Gillenwater HH, Kowalski RJ, Socinski MA, Lindley C.
    Cancer Chemother Pharmacol; 2001 May 01; 47(5):373-9. PubMed ID: 11391850
    [Abstract] [Full Text] [Related]

  • 11. Estimation of glomerular filtration rate with creatinine-based versus cystatin C-based equations in kidney transplant recipients.
    Savaj S, Shoushtarizadeh T, Abbasi MA, Razavimanesh SH, Ghods AJ.
    Iran J Kidney Dis; 2009 Oct 01; 3(4):234-8. PubMed ID: 19841528
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity.
    Bretagne M, Jouinot A, Durand JP, Huillard O, Boudou Rouquette P, Tlemsani C, Arrondeau J, Sarfati G, Goldwasser F, Alexandre J.
    Cancer Chemother Pharmacol; 2017 Jul 01; 80(1):45-53. PubMed ID: 28508095
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two.
    Tidman M, Sjöström P, Jones I.
    Nephrol Dial Transplant; 2008 Jan 01; 23(1):154-60. PubMed ID: 17911090
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the Modified Diet in Renal Disease equation for calculation of carboplatin dose.
    Shord SS, Bressler LR, Radhakrishnan L, Chen N, Villano JL.
    Ann Pharmacother; 2009 Feb 01; 43(2):235-41. PubMed ID: 19193580
    [Abstract] [Full Text] [Related]

  • 19. Performance of the creatinine-based and the cystatin C-based glomerular filtration rate (GFR) estimating equations in a heterogenous sample of patients referred for nuclear GFR testing.
    Huang SH, Macnab JJ, Sontrop JM, Filler G, Gallo K, Lindsay RM, Clark WF.
    Transl Res; 2011 Jun 01; 157(6):357-67. PubMed ID: 21575920
    [Abstract] [Full Text] [Related]

  • 20. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease.
    Kuan Y, Hossain M, Surman J, El Nahas AM, Haylor J.
    Nephrol Dial Transplant; 2005 Nov 01; 20(11):2394-401. PubMed ID: 16115853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.